Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of CM518D1 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial of CM518D1 in patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab [Phase 1]
An open-label Phase 1 dose-escalation trial of BDB001 in combination with atezolizumab for solid tumors, which has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study [Phase 1, Phase 2]
This document reports the completion of a long-term safety study of tazemetostat in adults who previously received the drug in earlier trial…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Remote Monitoring in Cancer Care: A Platform Study
Completed results of a Mayo Clinic platform study evaluating remote monitoring in cancer care across head and neck cancer, hematologic malig…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study of ABBV-303 alone or in combination with Budigalimab (ABBV-181) in adults with advanced solid tumors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes [Phase 1]
Phase 1 pharmacokinetic study update characterizes belinostat exposure across patients with different UGT1A1*28 genotypes (wild-type, hetero…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors [Phase 1]
This first-in-human Phase 1 study of BAY2862789 aims to assess safety, determine the recommended dose, characterize pharmacokinetics/pharmac…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors [Phase 1]
Phase Ib study evaluating a combination of metformin, digoxin, and simvastatin in advanced pancreatic cancer and other solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children [Phase 1]
Phase 1 pediatric trial update evaluating carfilzomib with cyclophosphamide and etoposide for relapsed or refractory solid tumors and leukem…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1a/1b study of ACTM-838 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) [Phase 1]
This Phase 1 trial update reports on MK-4464 as a monotherapy and in combination with pembrolizumab for participants with advanced or metast…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial [NA]
A completed pragmatic clinical trial at Mayo Clinic evaluating enhanced, electronic health record–facilitated cancer symptom control; result…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 ADME trial assessing absorption, distribution, metabolism, and excretion of radiolabeled Subasumstat in adults with advanced or meta…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the safety and tolerability of ATB-320 in participants with progressive or metastatic solid tumors. The st…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy [Phase 4]
Phase 4 rollover study of sacituzumab govitecan-hziy in participants with metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors [Phase 1]
This document reports an ongoing Phase 1 study of ZV0203 for patients with HER2-positive advanced solid tumors, currently enrolling by invit…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers [NA]
Clinical trial assessing a positive activities intervention to improve quality of life for cancer patients and their caregivers in collectiv…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Retun-to-school Adaptation Program for Children With Cancer [NA]
Clinical trial update indicating the completion of a return-to-school adaptation program study for children with cancer, sponsored by Gazi U…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors [Phase 1]
A Phase 1 clinical trial update indicating BL-M02D1 for locally advanced or metastatic digestive tract tumors and other solid tumors is curr…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]
Phase I/II study evaluating LM-2417 in adults with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of INCB086550 in patients with solid tumors; the trial status is t…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of nivolumab and ipilimumab in adults with HIV-associated relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a trastuzumab-based CAR-T therapy targeting HER2-positive advanced breast cancer and other solid tumors…